SANDRA FRENCH: Open Payments
NPI 1487823910 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 50 payments from 12 companies in 2025. Trend: 2023 $1,497 · 2024 $973 · 2025 $1,195
Food & beverage: $926Education: $270
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $293 |
| Galderma Laboratories, L.P. | 10 | $263 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $195 |
| Regeneron Healthcare Solutions, Inc. | 5 | $108 |
| Lilly USA, LLC | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| ABBVIE INC. | 3 | $57 |
| Amgen Inc. | 2 | $43 |
| UCB, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $18 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, TALTZ, COSENTYX, AKLIEF, OTEZLA, Bimzelx.
Industry payments across TN — which companies pay providers there.
